High-throughput screening: today's biochemical and cell-based approaches

V Blay, B Tolani, SP Ho, MR Arkin - Drug Discovery Today, 2020 - Elsevier
Highlights•Self-contained overview of current high-throughput screening technologies.•
Expands on the current use of most recent tools, like high-throughput microscopy.•Learn …

Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling

A Skardal, T Shupe, A Atala - Drug discovery today, 2016 - Elsevier
Highlights•Traditional drug screening model systems are inadequate.•Organoid-on-a-chip
platforms stand to significantly advance drug and toxicology screening.•A wide variety or …

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

RJ Weaver, EA Blomme, AE Chadwick… - Nature Reviews Drug …, 2020 - nature.com
Drug-induced liver injury (DILI) is a patient-specific, temporal, multifactorial
pathophysiological process that cannot yet be recapitulated in a single in vitro model …

Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays

SN Rampersad - Sensors, 2012 - mdpi.com
Accurate prediction of the adverse effects of test compounds on living systems, detection of
toxic thresholds, and expansion of experimental data sets to include multiple toxicity end …

Nanomedicine applied to translational oncology: A future perspective on cancer treatment

L Bregoli, D Movia, JD Gavigan-Imedio… - … , Biology and Medicine, 2016 - Elsevier
The high global incidence of cancer is associated with high rates of mortality and morbidity
worldwide. By taking advantage of the properties of matter at the nanoscale, nanomedicine …

A human liver microphysiology platform for investigating physiology, drug safety, and disease models

LA Vernetti, N Senutovitch, R Boltz… - Experimental …, 2016 - journals.sagepub.com
This paper describes the development and characterization of a microphysiology platform
for drug safety and efficacy in liver models of disease that includes a human, 3D …

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses

L Eyer, R Nencka, E de Clercq… - Antiviral Chemistry …, 2018 - journals.sagepub.com
Nucleoside analogs represent the largest class of small molecule-based antivirals, which
currently form the backbone of chemotherapy of chronic infections caused by HIV, hepatitis …

iPSC-derived hepatocytes as a platform for disease modeling and drug discovery

JL Corbett, SA Duncan - Frontiers in medicine, 2019 - frontiersin.org
The liver is one of the largest organs in the body and is responsible for a diverse repertoire
of metabolic processes. Such processes include the secretion of serum proteins …

Development of a functional airway-on-a-chip by 3D cell printing

JY Park, H Ryu, B Lee, DH Ha, M Ahn, S Kim… - …, 2018 - iopscience.iop.org
We used 3D cell printing to emulate an airway coupled with a naturally-derived blood vessel
network in vitro. Decellularized extracellular matrix bioink derived from porcine tracheal …

Organ-on-a-chip engineering: Toward bridging the gap between lab and industry

Q Ramadan, M Zourob - Biomicrofluidics, 2020 - pubs.aip.org
Organ-on-a-chip (OOC) is a very ambitious emerging technology with a high potential to
revolutionize many medical and industrial sectors, particularly in preclinical-to-clinical …